• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人卵巢癌中的组织蛋白酶D活性]

[Cathepsin D activity in human ovarian carcinoma].

作者信息

Reich W, Wagner F, Hofmann K D, Marzotko F, Schmeisser G

出版信息

Zentralbl Gynakol. 1984;106(3):196-200.

PMID:6702349
Abstract

In the tissue of 54 ovarian carcinomas and 38 normal human ovaries the activity of cathepsin D was determined by means of the Anson-method. In ovarian carcinomas the mean activity of cathepsin D was 4515 pmol T/s/g tissue, in normal ovarian tissue only 2119 pmol T/s/g. The difference is significant (p less than 0,001). The dependency on age of the activity of cathepsin D suitable for normal ovary, got lost in cancer tissue. There is no relationship between the amount of activity of cathepsin D and the stage of the tumour. Extreme high activities of cathepsin D were found in metastatic ovarian carcinomas. The activity of cathepsin D is higher in endometrioid and papillary than in mucigenous and hypernephroid ovarian carcinomas. The different activities of cathepsin D were discussed with regard to the invasive growth of cancer and to deranged protein metabolism.

摘要

采用安森法测定了54例卵巢癌组织及38例正常人类卵巢组织中组织蛋白酶D的活性。卵巢癌组织中组织蛋白酶D的平均活性为4515 pmol T/s/g组织,而正常卵巢组织中仅为2119 pmol T/s/g。差异具有显著性(p<0.001)。正常卵巢中组织蛋白酶D活性对年龄的依赖性在癌组织中消失。组织蛋白酶D的活性量与肿瘤分期之间没有关系。在转移性卵巢癌中发现组织蛋白酶D活性极高。子宫内膜样癌和乳头状癌中组织蛋白酶D的活性高于黏液性癌和肾样癌。就癌症的侵袭性生长和蛋白质代谢紊乱讨论了组织蛋白酶D的不同活性。

相似文献

1
[Cathepsin D activity in human ovarian carcinoma].[人卵巢癌中的组织蛋白酶D活性]
Zentralbl Gynakol. 1984;106(3):196-200.
2
Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer.组织蛋白酶B和D在正常卵巢、卵巢良性肿瘤及上皮性卵巢癌中的活性及活性比率
J Soc Gynecol Investig. 2005 Oct;12(7):539-44. doi: 10.1016/j.jsgi.2005.06.009.
3
[LDH activity in human ovarian tissue and in ovarian carcinoma (author's transl)].人卵巢组织及卵巢癌中的乳酸脱氢酶活性(作者译)
Zentralbl Gynakol. 1982;104(8):463-6.
4
[Concentration of ascorbic acid in tissue of ovarian carcinoma (author's transl)].卵巢癌组织中抗坏血酸的浓度(作者译)
Zentralbl Gynakol. 1980;102(3):168-70.
5
Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.组织蛋白酶D在卵巢癌中的预后价值及其与p53表达和微血管密度的相关性
Gynecol Oncol. 2004 Feb;92(2):545-52. doi: 10.1016/j.ygyno.2003.11.016.
6
Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.卵巢囊腺瘤、低恶性潜能肿瘤及浸润性癌中端粒酶活性分析。
Gynecol Oncol. 1999 Sep;74(3):338-45. doi: 10.1006/gyno.1999.5506.
7
Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.结直肠癌中组织蛋白酶B和D的活性:与肿瘤芽生的关系
Anticancer Res. 2004 Sep-Oct;24(5A):2847-51.
8
[Proteolytic lysosomal enzymes in ovarian cancer].
Vopr Med Khim. 1991 Jul-Aug;37(4):20-3.
9
Type 2 11beta-hydroxysteroid dehydrogenase activity in human ovarian cancer.人卵巢癌中的2型11β-羟基类固醇脱氢酶活性
Steroids. 2006 Nov;71(11-12):1019-23. doi: 10.1016/j.steroids.2006.09.001. Epub 2006 Oct 9.
10
Prognostic markers in node-negative breast cancer: a prospective study.腋窝淋巴结阴性乳腺癌的预后标志物:一项前瞻性研究。
Cytometry B Clin Cytom. 2004 May;59(1):24-31. doi: 10.1002/cyto.b.20003.

引用本文的文献

1
Cathepsin-D expression in cervical carcinoma and its prognostic significance.
Virchows Arch A Pathol Anat Histopathol. 1993;422(5):357-60. doi: 10.1007/BF01605453.